YH35324

DRUG3 trials

Sponsors

Yuhan Corporation

Conditions

Adult Subjects With Allergic DiseasesAdult Subjects with Mild Allergic DiseasesAllergic DiseaseAtopic Healthy SubjectsChronic Inducible UrticariaChronic Spontaneous UrticariaCold Urticaria

Phase 1

A FIH Study of YH35324 in Atopic Healthy Subjects or Subjects with Mild Allergic Diseases

CompletedNCT05061524

Yuhan CorporationAdult Subjects with Mild Allergic Diseases, Atopic Healthy Subjects

Start: 2021-09-26End: 2023-01-25Updated: 2024-12-03

A Multiple Ascending Dose, Phase 1b Study of YH35324 in Atopic Healthy Subjects or Subjects With Allergic Diseases

CompletedNCT05564221

Yuhan CorporationAdult Subjects With Allergic Diseases, Atopic Healthy Subjects

Start: 2022-11-01End: 2024-11-28Updated: 2025-01-24

A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases

CompletedNCT05960708

Yuhan CorporationAllergic Disease, Chronic Inducible Urticaria, Chronic Spontaneous Urticaria +1

Start: 2023-08-23End: 2024-09-13Updated: 2024-11-22